Nanosonics
Dr Fisher has been a member of the Board since July 2001. Dr Fisher is a founding partner of Brandon Capital Partners, a leading Australian venture capital provider. He has more than 35 years’ extensive operating experience in the biotechnology and healthcare industry in Australia and overseas. He held senior positions with Pharmacia AB (now part of Pfizer, Inc) and was CEO of Peptech Limited (now part of Cephalon Inc. (Nasdaq:CEPH). He has not held any directorships of other listed companies in the last 3 years.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Nanosonics
1 followers
Nanosonics Ltd is an Australia-based company focused on developing automated disinfection technology. The Company's principal activities include manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories and research, development and commercialization of infection control and decontamination products and related technologies. The Company's automated Trophon electron paramagnetic resonance (EPR) disinfection device provides solutions for care in ultrasound probe disinfection practices. trophon is its solution for reducing cross contamination between patients and reducing the spread of Healthcare Acquired Infections (HAIs). Its trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection. Its consumable and accessories include NanoNebulant, trophon Chemical Indicator, trophon AcuTrace Operator Card and trophon Printer.